z-logo
open-access-imgOpen Access
Update on Clinical Options for the Management of Allergic Rhinitis
Author(s) -
Mohsen Nasir,
J. A. Grant
Publication year - 2011
Publication title -
clinical medicine insights therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.205
H-Index - 9
ISSN - 1179-559X
DOI - 10.4137/cmt.s6375
Subject(s) - medicine , nasal administration , nasal decongestant , chronic sinusitis , anticholinergic , immunotherapy , allergy , intensive care medicine , quality of life (healthcare) , immunology , sinusitis , pharmacology , immune system , anesthesia , nursing
Allergic rhinitis is a common, chronic medical condition affecting millions of people worldwide. Uncontrolled disease has been associated with impairments in quality of life and decreased economic productivity. Proper identification and control of relevant co-morbid conditions is essential for optimal rhinitis control. Management of allergic rhinitis includes identification of relevant allergens, education on avoidance measures, medications and immunotherapy. First-line therapy includes the use on an intranasal steroid. Other treatment options include oral or intranasal antihistamines, decongestants, leukotriene receptor antagonists, mast cell stabilizers or anticholinergic agents. Immunotherapy is an effective treatment option for refractory disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom